Influx Healthtech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	1,049	999.65	760.57	592.02	-
Revenue Growth (YoY)	4.89%	31.44%	28.47%	-	-
Cost of Revenue	639.48	656.01	528.63	456.38	-
Gross Profit	409.05	343.65	231.94	135.64	-
Selling, General & Admin	100.29	82.21	61.45	39.8	0.03
Other Operating Expenses	102.06	91.61	63.25	34.15	0.01
Operating Expenses	230.6	192.36	134.08	75.16	0.04
Operating Income	178.46	151.28	97.86	60.48	-0.04
Interest Expense	-0.01	-1.71	-0.1	-0.05	-
Interest & Investment Income	0.56	0.23	-	-	-
Currency Exchange Gain (Loss)	-0.22	0.01	-	-	-
Other Non Operating Income (Expenses)	0	-0.48	-0.4	-0.37	-0.05
Pretax Income	178.79	149.33	97.36	60.06	-0.09
Income Tax Expense	45.13	38.05	25.4	15.69	-
Net Income	133.66	111.28	71.96	44.37	-0.09
Net Income to Common	133.66	111.28	71.96	44.37	-0.09
Net Income Growth	20.11%	54.63%	62.20%	-	-
Shares Outstanding (Basic)	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18
Shares Change (YoY)	-	-	-0.00%	0.00%	-
EPS (Basic)	7.36	6.13	3.96	2.44	-0.00
EPS (Diluted)	7.36	6.13	3.96	2.44	-0.00
EPS Growth	20.06%	54.80%	62.00%	-	-
Free Cash Flow	-11.55	5.83	19.43	0.49	-
Free Cash Flow Per Share	-0.64	0.32	1.07	0.03	-
Gross Margin	39.01%	34.38%	30.50%	22.91%	-
Operating Margin	17.02%	15.13%	12.87%	10.22%	-
Profit Margin	12.75%	11.13%	9.46%	7.49%	-
Free Cash Flow Margin	-1.10%	0.58%	2.55%	0.08%	-
EBITDA	206.63	169.74	107.19	61.7	-
EBITDA Margin	19.71%	16.98%	14.09%	10.42%	-
D&A For EBITDA	28.17	18.46	9.33	1.22	-
EBIT	178.46	151.28	97.86	60.48	-0.04
EBIT Margin	17.02%	15.13%	12.87%	10.22%	-
Effective Tax Rate	25.24%	25.48%	26.09%	26.13%	-
Revenue as Reported	1,050	1,000	760.57	592.02	-
Advertising Expenses	0.19	0.2	1.25	0.14	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.